Fedha

Hisa unazofuatilia
4568:TYO
Daiichi Sankyo Co Ltd
JP¥ 2,709.00
-1.15%
(-31.50) Siku 1
2 Okt, 15:30:00 GMT +9  ·   JPY
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya 4568...
Fungua
JP¥ 2,720
Juu
JP¥ 2,751
Chini
JP¥ 2,704
Mtaji wa soko
5.05T
Wastani wa kiasi cha mauzo
6.01M
Kiasi cha mauzo ya hisa
5.14M
Gawio
2.88%
Mgawo wa faida wa kila robo mwaka
JP¥ 20
Uwiano wa bei ya hisa na mapato kwa kila hisa
20.52
Juu kwa wiki 52
JP¥ 4,178
Chini kwa wiki 52
JP¥ 2,390
EPS
JP¥ 132
Hisa za wawekezaji
647.77M
Idadi ya wafanyakazi
elfu 20
Fungua
JP¥ 2,720
Juu
JP¥ 2,751
Chini
JP¥ 2,704
Mtaji wa soko
5.05T
Wastani wa kiasi cha mauzo
6.01M
Kiasi cha mauzo ya hisa
5.14M
Gawio
2.88%
Mgawo wa faida wa kila robo mwaka
JP¥ 20
Uwiano wa bei ya hisa na mapato kwa kila hisa
20.52
Juu kwa wiki 52
JP¥ 4,178
Chini kwa wiki 52
JP¥ 2,390
EPS
JP¥ 132
Hisa za wawekezaji
647.77M
Idadi ya wafanyakazi
elfu 20
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey. Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries. Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
Kuhusu Daiichi Sankyo Co Ltd
Afisa Mkuu Mtendaji (CEO)Hiroyuki Okuzawa
Wafanyakazielfu 20.2
Lilianzishwa28 Sep 2005
Makao makuuChuo City, Tokyo, Japani
Sekta-
Ripoti ya mwisho
31 Jul 2026
Kipindi cha Kifedha
Robo1 2027
Mapato kwa kila hisa dhidi ya makadirio (JPY)
- / -
Mapato dhidi ya makadirio (JPY)
574.74B / 533.58B
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 1 ya mwaka wa fedha wa 2027
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika JPY
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika JPY
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
500.76B
558.11B
589.59B
574.74B
Gharama ya bidhaa zilizouzwa
155.98B
118.28B
302.44B
124.29B
Gharama ya mapato
155.98B
118.28B
302.44B
124.29B
Gharama za utafiti na maendeleo
111.72B
122.11B
126.23B
115.46B
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
189.08B
228.23B
154.06B
249.96B
Gharama ya uendeshaji
297.25B
350.29B
279.38B
365.35B
Jumla ya gharama za uendeshaji
453.23B
468.57B
581.82B
489.64B
Mapato ya uendeshaji
47.52B
89.54B
7.77B
85.10B
Mapato mengine yasiyo ya uendeshaji
-
-
6.22B
-2.00M
EBT ikijumuisha vipengee visivyo vya kawaida
57.78B
106.73B
22.44B
91.34B
EBT bila kujumuisha vipengee visivyo vya kawaida
57.78B
106.73B
7.84B
91.34B
Gharama ya kodi ya mapato
12.46B
20.10B
-39.84B
22.70B
Kiwango cha kodi kinachotumika
21.57%
18.83%
-177.52%
24.86%
Gharama nyingine za uendeshaji
-3.56B
-49.00M
-908.00M
-69.00M
Mapato halisi
45.31B
86.63B
62.28B
68.64B
Kiwango cha faida halisi
9.05%
15.52%
10.56%
11.94%
Mapato kwa kila hisa
-
-
-
-
Mapato ya riba na uwekezaji
10.68B
19.08B
377.00M
9.74B
Gharama ya riba
-834.00M
-2.16B
-18.91B
-3.23B
Jumla ya gharama halisi za riba
9.84B
16.91B
-18.53B
6.51B
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
66.41B
109.18B
28.89B
106.58B
Faida au hasara kutokana na uuzaji wa vipengee
1.75B
573.00M
8.50B
180.00M
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google